Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study.

Christiaens, Antoine; Baretella, Oliver; Del Giovane, Cinzia; Rodondi, Nicolas; Knol, Wilma; Peters, Mike; Jennings, Emma; O'Mahony, Denis; Spinewine, Anne; Boland, Benoit; Henrard, Séverine (2023). Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study. Age and ageing, 52(1), afac320. Oxford University Press 10.1093/ageing/afac320

[img]
Preview
Text
afac320.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (432kB) | Preview

BACKGROUND

Diabetes overtreatment is a frequent and severe issue in multimorbid older patients with type 2 diabetes (T2D).

OBJECTIVE

This study aimed at assessing the association between diabetes overtreatment and 1-year functional decline, hospitalisation and mortality in older inpatients with multimorbidity and polypharmacy.

METHODS

Ancillary study of the European multicentre OPERAM project on multimorbid patients aged ≥70 years with T2D and glucose-lowering treatment (GLT). Diabetes overtreatment was defined according to the 2019 Endocrine Society guideline using HbA1c target range individualised according to the patient's overall health status and the use of GLT with a high risk of hypoglycaemia. Multivariable regressions were used to assess the association between diabetes overtreatment and the three outcomes.

RESULTS

Among the 490 patients with T2D on GLT (median age: 78 years; 38% female), 168 (34.3%) had diabetes overtreatment. In patients with diabetes overtreatment as compared with those not overtreated, there was no difference in functional decline (29.3% vs 38.0%, P = 0.088) nor hospitalisation rates (107.3 vs 125.8/100 p-y, P = 0.115) but there was a higher mortality rate (32.8 vs 21.4/100 p-y, P = 0.033). In multivariable analyses, diabetes overtreatment was not associated with functional decline nor hospitalisation (hazard ratio, HR [95%CI]: 0.80 [0.63; 1.02]) but was associated with a higher mortality rate (HR [95%CI]: 1.64 [1.06; 2.52]).

CONCLUSIONS

Diabetes overtreatment was associated with a higher mortality rate but not with hospitalisation or functional decline. Interventional studies should be undertaken to test the effect of de-intensifying GLT on clinical outcomes in overtreated patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Baretella, Oliver, Del Giovane, Cinzia, Rodondi, Nicolas

Subjects:

300 Social sciences, sociology & anthropology > 360 Social problems & social services
600 Technology > 610 Medicine & health

ISSN:

1468-2834

Publisher:

Oxford University Press

Funders:

[222] Horizon 2020 ; [201] Staatssekretariat für Bildung, Forschung und Innovation (SBFI) = Swiss State Secretariat for Education, Research and Innovation (SERI)

Language:

English

Submitter:

Pubmed Import

Date Deposited:

12 Jan 2023 12:07

Last Modified:

19 Jan 2023 10:44

Publisher DOI:

10.1093/ageing/afac320

PubMed ID:

36626323

Uncontrolled Keywords:

diabetes overtreatment glucose-lowering treatment multimorbidity older patients older people type 2 diabetes

BORIS DOI:

10.48350/177175

URI:

https://boris.unibe.ch/id/eprint/177175

Actions (login required)

Edit item Edit item
Provide Feedback